After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, INVA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Innoviva Inc is $1.26B. A total of 0.68 million shares were traded on the day, compared to an average of 501.87K shares.
In the most recent transaction, Zhen Marianne sold 10,994 shares of INVA for 13.99 per share on Nov 15 ’23. After the transaction, the Chief Accounting Officer now owns 40,158 company shares.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, INVA has a high of $21.28 and a low of $13.39.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. INVA’s latest balance sheet shows that the firm has $201.53M in Cash & Short Term Investments as of fiscal 2021. There were $394.76M in debt and $5.81M in liabilities at the time. Its Book Value Per Share was $10.68, while its Total Shareholder’s Equity was $525.93M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INVA is Buy with a score of 4.00.
